Karschnia, Philipp; Young, Jacob S; Dono, Antonio; Häni, Levin; Juenger, Stephanie T; Sciortino, Tommaso; Bruno, Francesco; Teske, Nico; Morshed, Ramin A; Haddad, Alexander F; Zhang, Yalan; Stoecklein, Sophia; Vogelbaum, Michael A; Beck, Juergen; Tandon, Nitin; Hervey-Jumper, Shawn; Molinaro, Annette M; Rudà, Roberta; Bello, Lorenzo; Schnell, Oliver; Esquenazi, Yoshua; Ruge, Maximilian I; Grau, Stefan J; van den Bent, Martin; Weller, Michael; Berger, Mitchel S; Chang, Susan M; Tonn, Joerg-Christian (2022). TERT promotor status does not add prognostic information in IDH-wildtype glioblastomas fulfilling other diagnostic WHO criteria: A report of the RANO resect group. Neuro-oncology advances, 4(1):vdac158.
Statistics
Citations
Dimensions.ai Metrics
Altmetrics
Downloads
Additional indexing
Item Type: | Journal Article, refereed, further contribution |
---|---|
Communities & Collections: | 04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology |
Dewey Decimal Classification: | 610 Medicine & health |
Scopus Subject Areas: | Health Sciences > Neurology (clinical)
Health Sciences > Oncology Health Sciences > Surgery |
Uncontrolled Keywords: | General Medicine |
Language: | English |
Date: | 1 January 2022 |
Deposited On: | 08 Feb 2023 07:11 |
Last Modified: | 09 Feb 2023 21:00 |
Publisher: | Oxford University Press |
ISSN: | 2632-2498 |
OA Status: | Gold |
Free access at: | Publisher DOI. An embargo period may apply. |
Publisher DOI: | https://doi.org/10.1093/noajnl/vdac158 |
Users (please log in): Suggest update or correction for this item
For submitters/editors: Edit metadata
Permanent URL: https://doi.org/10.5167/uzh-230038
Download
Links
Authors, Affiliations, Collaborations
Ludwig-Maximilians-Universität München, Munich, Germany
Partner Site Munich, Munich, Germany
Partner Site Munich, Munich, Germany
University of San Francisco, San Francisco, United States
University of Texas Medical School at Houston, Houston, United States
Universität Freiburg im Breisgau, Freiburg im Breisgau, Germany
University of Cologne, Koln, Germany
Università degli Studi di Milano, Milan, Italy
Università degli Studi di Torino, Turin, Italy
Ludwig-Maximilians-Universität München, Munich, Germany
Partner Site Munich, Munich, Germany
Partner Site Munich, Munich, Germany
University of San Francisco, San Francisco, United States
University of San Francisco, San Francisco, United States
University of San Francisco, San Francisco, United States
Klinikum der Universität München, Munich, Germany
Moffitt Cancer Center, Tampa, United States
Universität Freiburg im Breisgau, Freiburg im Breisgau, Germany
University of Texas Medical School at Houston, Houston, United States
University of San Francisco, San Francisco, United States
University of San Francisco, San Francisco, United States
Università degli Studi di Torino, Turin, Italy
Castelfranco Veneto and Treviso Hospital, Treviso, Italy
Castelfranco Veneto and Treviso Hospital, Treviso, Italy
Università degli Studi di Milano, Milan, Italy
Universität Freiburg im Breisgau, Freiburg im Breisgau, Germany
University of Texas Medical School at Houston, Houston, United States
Uniklinik Köln, Koln, Germany
University of Cologne, Koln, Germany
Philipps-Universität Marburg, Marburg, Germany
Philipps-Universität Marburg, Marburg, Germany
Erasmus MC Cancer Institute, Rotterdam, Netherlands
UniversitatsSpital Zurich, Zurich, Switzerland
University of San Francisco, San Francisco, United States
University of San Francisco, San Francisco, United States

Ludwig-Maximilians-Universität München, Munich, Germany
Partner Site Munich, Munich, Germany
Partner Site Munich, Munich, Germany
Source of ORCID ID: Import from Crossref